Printer Friendly

Articles from The Fly (June 22, 2020)

1-150 out of 150 article(s)
Title Author Type Words
21Vianet announces $150M investment from Blackstone. 280
Affimed N.V. announces presentation of data on Genentech's RO7297089. 382
Alaska Air to start flying Embraer 175 aircraft in state of Alaska. 151
Alibaba, Yiwu City expand eWTP partnership. 186
Alkermes up after share buying called out as 'interesting'. 160
Alkermes, Clovis present 'positive' preclinical data from study of ALKS 4230. 236
Allogene says preclinical findings support DLL3-targeted AlloCAR-T in SCLC. 182
Altimmune announces IND clearance for Phase 2 trial of HepTcell. 482
Apple announces iPadOS 14 with new features for calls, Siri, and Search. 177
Apple introduces iOS 14. 210
Applied Genetic provides update on productivity, quality improvements. 216
Apyx Medical approved to sell Helium Plasma products in 5 new countries. 230
Aqua Metals completes initial run of first V1.25 electrolyzer. 241
Arcutis Biotherapeutics enrolls last patient in Phase 2 PoC trial of ARQ-154. 429
Arcutis CEO sees data readout in seborrheic dermatitis before year-end. 190
Arcutis CEO sees plaque psoriasis data in first half of 2021. 326
Aridis Pharmaceuticals reports results from Phase 1 portion of AR-501 trial. Financial report 218
ARK Restaurants reports Q2 EPS (51c) vs. (19c) last year. Financial report 177
Ascendis Pharma announces presentation of data for TransCon IL-2. 172
Asian Market Update:. 202
Assembly Biosciences announces data from immuno-oncology microbiome program. 214
Athenex announces $225M loan agreement with Oaktree. 152
aTyr Pharma presents preclinical research on NRP2 antibody effects. 183
Autolus Therapeutics presents preclinical data on AUTO3, AUTO6NG. 658
Barclays turns positive on lodging, upgrades Hilton to Overweight. 174
Barclays turns positive on lodging, upgrades Marriott to Overweight. 175
Barclays upgrades DiamondRock on 'drive-to' resort exposure. 180
Barrick Gold begins drilling on Loncor JV ground in DRC. 358
BBX Capital announces Bluegreen Vacations update. 332
BeiGene, SpringsWorks present preclincal data on lifirafenib with mirdametinib. 259
Beyond Air presents preclinical data on nitric oxide. 223
Beyond Air reports Q4 EPS (36c), consensus (38c). Financial report 196
Bicycle Therapeutics presents new data for BT5528. 366
Bluegreen Vacations provides update on business operations. 310
BRP Group announces offering of 11.5M shares of Class A common stock. 165
California to pull sports betting bill due to tribal opposition, Bloomberg says. 161
Carnival extends operational pause in North America through September 30. 307
CEO expects Arcutis to make clinical timelines despite COVID crisis. 339
CEO sees Arcutis '151, '154 emerging as preferred AD, psoriasis treatments. 680
Chicken Soup for the Soul announces 'viewer-first' initiatives for Crackle Plus. 289
Chicken Soup for the Soul announces 200 hours of programming for Crackle Plus. 156
Citron sets $30 price target on Sonos, repeats speculation of Apple M&A appeal. 258
Contango Oil & Gas reports Q1 EPS (80c), one est. (10c). 391
Contura Energy idles Kielty Mine due to market conditions. 267
Corbus Pharmaceuticals reports last subject visit in Phase 2b study of lenabasum. Clinical report 212
Curaleaf signs amended agreement for Grassroots acquisition. 451
CytomX announces preclinical data from Anti-CTLA-4 probody therapeutic programs. 202
Deciphera announces Health Canada authorizes sale of Qinlock. 268
Diebold reports preliminary YTD revenue of $1.4B, down 17.4% y/y. Financial report 172
Digital Ally regains compliance with Nasdaq requirement. 336
Disney to begin Disneyland Paris phased reopening on July 15. 202
Esperion, Daiichi Sankyo Europe amend license agreement. 172
Essa Pharma presents new preclinical data on EPI-7386. 230
Evelo Biosciences advances EDP1815 to Phase 2/3 TACTIC-E COVID-19 Trial. 421
Fly Intel: Top five analyst downgrades. 216
Fly Intel: Top five analyst upgrades. 218
FSD Pharma reports topline results form Phase 1 of ultramicronized PEA. Financial report 194
FuelCell resumes manufacturing at Torrington facility. 233
Fuling Global receives non-binding proposal to acquire company for $2.18/share. 254
FX Action: USD-CAD pegged a one-week high. 208
FX Update: The dollar dropped back. 345
FX Update: The risk-sensitive currencies rebounded from early losses. 336
GDS Holdings announces equity investment by Hillhouse, STT GDC. 153
General Dynamics awarded $869.04M Navy contract modification. 275
Genocea presents preclinical data on inhibigen biology. 195
Gilead to start human testing of inhaled version of remdesivir. 309
Hepion Pharmaceuticals saw antifibrotic activity for CRV431 in renal fibrosis. 238
Hookipa Pharma announces Phase 2 interim safety results for HB-101. Financial report 389
Hudbay Minerals advances appeal of Rosemont court decision. 200
Huntsman sees Q2 revenue down approximately 30%-35% y/y, consensus $1.12B. Financial report 206
Innovative Industrial Properties expands real estate partnership with Green Leaf. 191
Invitae to acquire ArcherDX in deal valued at approximately $1.4B. 151
Jazz reports lawsuits filed related to Xyrem, says allegations 'meritless'. 354
Jounce Therapeutics presents preclinical data on JTX-1811. 374
Karyopharm announces FDA approval of Xpovio. 155
Kazia Therapeutics presents further paxalisib, cantrixil data. 323
Kelly Services appoints Jim Bradley as CAO. 193
KeyBanc boosts Livongo target to $85, says yes, you can keep buying. 188
Kirkland Lake Gold appoints Greg Gibson as special advisor to CEO. 213
KORR Acquisitions sends follow-up letter to GoPro. 430
Leju receives NYSE notification regarded delayed Form 20-F filing. 184
LeMaitre Vascular acquires Artegraft for $90M. 194
Live Nation announces 'first ever U.S. drive-in concert series' amid lockdowns. 270
Livent announces proposed private offering of $225M of convertible senior notes. 220
Lyft resolves Americans with Disabilities Act allegations with DOJ. 202
MacroGenics announces presentation of preclinical data at AACR meeting. 435
Medtronic Evolut TAVI system receives expanded indication in Europe. 230
Merck: V114 met safety, immunogenicity objectives in Phase 3 studies. 161
Mersana Therapeutics presents preclinical data on XMT-1592. 283
Microsoft acquiring CyberX to complement existing Azure IoT security. 211
Microsoft closes operations side of Mixer, partners with Facebook Gaming. 247
Miragen Therapeutics says MRG-229 demonstrates antifibrotic activity in vitro. 225
Molecular Templates highlights ETB platform at AACR Annual Meeting. 596
Molecular Templates provides update on Phase 1 study of MT-5111. 310
Morgan Stanley sees Eliquis patent being upheld, ruling being 'imminent'. 172
MyoKardia reports data from Phase 2a trial of danicamtiv. 783
Myovant Sciences announces priority review, FDA acceptance of NDA for relugolix. 186
MySize receives Notice of Allowance for U.S. patent. 159
Neoleukin Therapeutics presents preclinical data for NL-201. 536
Next 'SpongeBob' movie to launch on demand, CBS All Access, Variety says. 167
NYPD pushed 'conspiracy theories' about tainted Shake Shack shakes, NY Post says. 198
NYSEG, RG&E file rate case settlement with NYPSC. 186
Orgenesis, Leidos collaborate on potential treatment for COVID-19. 283
ORIC Pharmaceuticals presents preclinical data on ORIC-101, ORIC-533. 405
PagerDuty intends to offer $250M of convertible senior notes. 161
PDS Biotechnology announces publication of results of PDS0101 combination. Financial report 180
Pfizer announces initiation of four Phase 3 investigational vaccine studies. 153
PG&E completes initial stage of bankruptcy exit financing. 198
PG&E launches offerings of common stock, equity units. 288
Phio Pharmaceuticals presents data on potential for PH-804. 337
Precigen presents preclinical data for PRGN-3005 UltraCAR-T. 250
ProPetro Holding files formerly delinquent 2019 annual, quarterly reports. Financial report 220
Quanta reports LUMA selection for O&M agreement with PREPA. 226
Ready At Dawn Studios joining Facebook. 161
Revolution Medicines doses first patient in study of RMC-4630, PD-1 inhibitor. 310
Revolution Medicines gives R&D update on novel targeted cancer therapies. 173
Royal Caribbean, Cruises Investment to reorganize Pullmantur joint venture. 224
Rubius Therapeutics highlights preclinical data for RTX-321. 219
Sarepta, Codiak collaborate to research, develop exosome-based therapeutics. 311
Sherwin-Williams raises Q2 revenue view. Financial report 352
Snap VP of diversity apologizes for offensive Juneteenth filter, The Verge says. 178
Spirit Aero says Boeing directed it to reduce 2020 737 production plan. 201
SpringsWorks Therapeutics: Dosing begins in Phase 1b study of nirogacestat. 159
Sutro Biopharma presents new data on STRO-002. 235
T-Mobile commences stock transactions in connection with SoftBank monetization. 378
Teleflex: Data published shows UroLift System as superior treatment to Rezum. 257
Tetraphase receives 'superior' takeover proposal from La Jolla. 462
Theratechnologies announces new data on SORT1+ technology. 468
Today's U.S. existing home sales report undershot estimates. 235
Tonix Pharmaceuticals announces results from preclinical study of TNX-1700. 193
Treasury Action: Treasuries are idling with yields little changed as Wall Street rebounds. 162
Treasury Market Outlook: U.S. equity futures are firmer. 209
Treasury's $111 B 3- and 6-month bill sales were mixed. 271
TripAdvisor provides Q2 financial update. 575
Turning Point Therapeutics presents preclinical data on repotrectinib. 182
Turning Point Therapeutics presents preclinical data on repotrectinib. 386
U.S. equity futures are firmer. 160
Verastem reports results from VS-6766, defactinib combo study. 352
Verizon completes DSS technology trials in Texas, Minnesota. 224
ViralClear partners with Catalent on potential treatment for COVID-19. 178
Virgin Galactic signs Space Act Agreement with NASA. 219
W&T Offshore withdraws prior annual guidance. 225
Walgreens Boots Alliance to resume immunization services. 209
Watanabe sees Arcutis as 'innovation driven company'. 215
WeedMD launches medical vaporizers product line. 167
Wheaton Precious Metals unit signs non-binding term sheet with Caldas Gold. 269
Wirecard sees 'prevailing likelihood' EUR 1.9B does not exist. 289
Yintech Investment receives preliminary non-binding acquisition proposal. 262
Ziopharm completes enrollment of Phase 2 trial of IL-12 with Libtayo. 324
Zscaler announces proposed offering of $1B convertible senior notes due 2025. 299

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters